Skip to main content

PYYX

Pyxus International, Inc.
$3.30 -0.01 (-0.30%)
1 Down Day

Price & Indicators

50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.30 Open$3.30 Day$3.30–3.30 52W$2.25–5.70 Avg vol 30d1K Short int157 · 1.0d Short vol100% Last earningsJun 4, 2026 DataSep 2020–Jul 2026 Filing10-K · Jun 4
Equibles Rating blended score
Overall
Sell
Technical · trend & momentum Buy
+ Price vs 200-day avg · +8% above
Sentiment · smart money Bearish
Short interest · 0.00% of float · 1.0 days cover
Fundamentals Weak
EPS growth · −5% Y/Y

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Key facts
Market Cap
$81.21M
Shares
24,607,791
CIK
939930
Investor Relations
Investor relations
Up next
Next earnings call
Sep 7, 2026 Est · unconfirmed · in 10 wks
FQ2-27 quarter ends
~Sep 30, 2026 Est
filed Jun 4, 2026
Guidance & track record
Latest guidance · from the 8-K filed Jun 4, 2026
Sales · fiscal year ending March 31, 2027 $2.3B – $2.5B
Adjusted EBITDA · fiscal year ending March 31, 2027 $210M – $240M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
no cross Neutral
Price vs 200-day avg
+8% above Bullish
Price vs 50-day avg
+12% above Bullish
RSI (14)
54 · neutral Neutral
MACD trend
negative Bearish
52-week position
30% · mid-range Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $2 Now $3 · 30% 52-wk high $6
vs 200-day avg +8% vs 50-day avg +12%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $226.7M full-year fiscal 2026
Adjusted free cash flow non-GAAP $352.1M three months ended March 31, 2026
Cash flow from operations $310.1M three months ended March 31, 2026
Interest coverage 1.63 last twelve months at March 31, 2026
Leverage Ratio 3.52 at March 31, 2026
Tobacco inventory $786.7M fiscal year ended March 31, 2026
Uncommitted inventory $45.2M at March 31, 2026

Figures exactly as the company stated them · period links open the stating release · YoY needs the prior-year figure on file

Versus peers

Tobacco — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PYYX
Pyxus International, Inc.
this stock
$81.21M -6.3% 0.0%
PM
Philip Morris International Inc.
$281.96B +13.8% +10.7% 1.1%
BTI
British American Tobacco p.l.c.
$135.50B +12.4% 0.3%
MO
Altria Group, Inc.
$120.29B +26.9% -3.1% 3.1%
RLX
RLX Technology Inc.
$2.37B -16.2% +50.3% 0.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
157
Days to cover
1.0d
Change
+157 sh
View
Short Volume
Short vol %
100%
As of
Jul 1, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$14.6M
EPS diluted
$0.56
View
Buybacks
Authorized
$10.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 4, 2026
This year
4
View
Earnings & Events
Earnings Calls
Last call
Jun 4, 2026
View
Investor Relations
Latest news
Pyxus International, Inc. Reports…
Published
Jun 4, 2026
View

Performance

5D 20D 120D MTD YTD
PYYX -5.4% +32.0% +1.1% -0.3% -6.3%
SPY +1.8% -1.6% +7.9% -1.3% +9.5%
vs SPY -7.2% +33.6% -6.9% +1.0% -15.8%

Capital returns

Buyback program · as of Aug 15, 2024
Authorized
$10.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.